SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 74,900
-4,400 (-5.55%)
At close: Jul 14, 2026
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 6.21 trillion as of July 14, 2026. Its market cap has decreased by -12.86% in one year.
Market Cap
6.21T
Enterprise Value
5.95T
Revenue
790.25B
Ranking
n/a
PE Ratio
17.81
Stock Price
74,900.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 6.21T, a decrease of -37.56%. That is a compound annual growth rate of -7.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 6.21T | -36.36% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 17.35T |
| Samsung Epis Holdings | 9.57T |
| Kolon TissueGene | 7.65T |
| HLB Co., Ltd. | 4.87T |
| LigaChem Biosciences | 4.43T |
| D&D Pharmatech | 3.86T |
| Voronoi | 2.99T |
| SK bioscience | 2.88T |